Company intelligence / Profile preview

Cognixion

Santa Barbara, California, United Statescognixion.com ↗

Ownership: Private
Development stage: Commercial

Overview

Cognixion has developed a non-invasive BCI wearable platform integrating augmented reality and AI to enable communication for people with severe disabilities. The research version ("Axon-R") is available via Blackrock Neurotech's distribution network but not cleared by the FDA for therapeutic use. The clinical version ("Cognixion ONE Axon") has received FDA Breakthrough Device Designation. No published pivotal clinical trial results yet.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (Assistive communication device)Artificial intelligence platform
Industry: Assistive Medical Devices

Partnerships

Blackrock Neurotech (distribution of Axon-R research device)

Beyond the preview

Go deeper on Cognixion.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cognixion.

Explore the full profile